All Stories

  1. Molecular Docking and Molecular Dynamics Simulation Based Approach to Explore the Dual Inhibitor Against HIV-1 Reverse Transcriptase and Integrase

    Article • Combinatorial Chemistry & High Throughput Screening, December 2017, Bentham Science Publishers

    Mr Subhash chander, Professor Vijay Kumar Prajapati, Rajan Pandey, Bhanwar Singh Choudhary

  2. Arsenic Exposure and Outcomes of Antimonial Treatment in Visceral Leishmaniasis Patients in Bihar, India: A Retrospective Cohort Study

    Article • PLoS Neglected Tropical Diseases, March 2015, PLOS

    Professor Vijay Kumar Prajapati, Professor Alan H Fairlamb

  3. In vitro Susceptibility of Leishmania donovani to Miltefosine in Indian Visceral Leishmaniasis

    Article • American Journal of Tropical Medicine and Hygiene, August 2013, American Society of Tropical Medicine and Hygiene

    Professor Vijay Kumar Prajapati

  4. In vitro Antileishmanial Drug Susceptibility of Clinical Isolates from Patients with Indian Visceral Leishmaniasis--Status of Newly Introduced Drugs

    Article • American Journal of Tropical Medicine and Hygiene, August 2012, American Society of Tropical Medicine and Hygiene

    Professor Vijay Kumar Prajapati

  5. Drug Susceptibility in Leishmania Isolates Following Miltefosine Treatment in Cases of Visceral Leishmaniasis and Post Kala-Azar Dermal Leishmaniasis

    Article • PLoS Neglected Tropical Diseases, May 2012, PLOS

    Professor Vijay Kumar Prajapati

  6. Efficacy of Miltefosine in the Treatment of Visceral Leishmaniasis in India After a Decade of Use

    Article • Clinical Infectious Diseases, May 2012, Oxford University Press (OUP)

    Professor Vijay Kumar Prajapati

  7. An Oral Formulation of Amphotericin B Attached to Functionalized Carbon Nanotubes Is an Effective Treatment for Experimental Visceral Leishmaniasis

    Article • The Journal of Infectious Diseases, December 2011, Oxford University Press (OUP)

    Professor Vijay Kumar Prajapati

  8. Visceral Leishmaniasis and Arsenic: An Ancient Poison Contributing to Antimonial Treatment Failure in the Indian Subcontinent?

    Article • PLoS Neglected Tropical Diseases, September 2011, PLOS

    Professor Alan H Fairlamb, Professor Vijay Kumar Prajapati

  9. Unusual Case of Resistance to Amphotericin B in Visceral Leishmaniasis in a Region in India Where Leishmaniasis Is Not Endemic

    Article • Journal of Clinical Microbiology, May 2011, ASM Journals

    Professor Vijay Kumar Prajapati

  10. Evaluation of Blood Agar Microtiter Plates for Culturing Leishmania Parasites To Titrate Parasite Burden in Spleen and Peripheral Blood of Patients with Visceral Leishmaniasis

    Article • Journal of Clinical Microbiology, March 2010, ASM Journals

    Professor Vijay Kumar Prajapati

  11. Brief Definitive Report: Human visceral leishmaniasis is not associated with expansion or accumulation of Foxp3+ CD4 cells in blood or spleen

    Article • Parasite Immunology, March 2010, Wiley

    Professor Vijay Kumar Prajapati